Page last updated: 2024-08-24

atorvastatin and methylprednisolone

atorvastatin has been researched along with methylprednisolone in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (23.08)	29.6817
2010's	9 (69.23)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Devlin, J; Haroon, M	1
Cirkovic, MV; Djukanovic, BP; Gradinac, SDj; Jovic, MDj; Maravic-Stojkovic, VR; Milojevic, PS; Peric, MS; Vukovic, PM	1
Braitman, LE; Goldstein, DT; Handal, JA; John, TK; Khurana, JS; Saing, M; Samuel, SP	1
Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A	1
Jiang, H; Li, XL; Wang, MX; Yan, X; Yu, CM; Zhang, B; Zhang, WJ; Zhang, ZC	1
Bossuyt, X; Dobbels, L; Mahler, M; Van Damme, P	1
Albert, A; Bourré-Tessier, J; Drouin, J; Ferreira, J; Fritzler, MJ; Goulet, JR; Goulet, M; Landon-Cardinal, O; Rich, E; Robitaille, Y; Senécal, JL; Targoff, IN; Troyanov, Y	1
Ernste, F; Pitlick, M	1
Gao, YL; Guo, JJ; Wang, M; Wang, ZY; Yu, XF	1

Reviews

1 review(s) available for atorvastatin and methylprednisolone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for atorvastatin and methylprednisolone

Article	Year
Steroids and statins: an old and a new anti-inflammatory strategy compared. Perfusion, 2011, Volume: 26, Issue:1 Topics: Anti-Inflammatory Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Middle Aged; Pyrroles; Treatment Outcome; Ventricular Dysfunction, Left	2011
Atorvastatin calcium in combination with methylprednisolone for the treatment of multiple sclerosis relapse. International immunopharmacology, 2014, Volume: 23, Issue:2 Topics: Administration, Oral; Adult; Atorvastatin; Brain; Cytokines; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Spinal Cord; Treatment Outcome	2014

Article

Year

Steroids and statins: an old and a new anti-inflammatory strategy compared.

Perfusion, 2011, Volume: 26, Issue:1

Topics: Anti-Inflammatory Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Middle Aged; Pyrroles; Treatment Outcome; Ventricular Dysfunction, Left

2011

Atorvastatin calcium in combination with methylprednisolone for the treatment of multiple sclerosis relapse.

International immunopharmacology, 2014, Volume: 23, Issue:2

Topics: Administration, Oral; Adult; Atorvastatin; Brain; Cytokines; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Spinal Cord; Treatment Outcome

2014

Other Studies

10 other study(ies) available for atorvastatin and methylprednisolone

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A case of ANCA-associated systemic vasculitis induced by atorvastatin. Clinical rheumatology, 2008, Volume: 27 Suppl 2 Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Atorvastatin; Azathioprine; Heptanoic Acids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Pyrroles; Vasculitis	2008
Effect of atorvastatin on the cortical bones of corticosteroid treated rabbits. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2012, Volume: 30, Issue:6 Topics: Animals; Anticholesteremic Agents; Atorvastatin; Compressive Strength; Drug Interactions; Equipment Failure Analysis; Femur; Glucocorticoids; Heptanoic Acids; Injections, Intramuscular; Methylprednisolone; Pyrroles; Rabbits; Stress, Mechanical; Tibia	2012
Devic syndrome: can antiphospholipid antibodies be a factor? Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:8 Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin	2012
A 62-Year-Old Woman with Muscle Weakness. Clinical chemistry, 2015, Volume: 61, Issue:9 Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Muscle Weakness; Muscles	2015
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine, 2017, Volume: 96, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Autoantibodies; Autoimmune Diseases; Complement Membrane Attack Complex; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induction Chemotherapy; Longitudinal Studies; Male; Methylprednisolone; Middle Aged; Muscle, Skeletal; Polymyositis	2017
Anti-HMGCR myopathy presenting with acute systolic heart failure. BMJ case reports, 2019, May-08, Volume: 12, Issue:5 Topics: Aged; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Creatine Kinase; Female; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl CoA Reductases; Methylprednisolone; Muscle Weakness; Muscular Diseases; Treatment Outcome	2019
Acute bilateral cerebral infarction in the presence of neuromyelitis optica spectrum disorder: A case report. Medicine, 2020, Oct-02, Volume: 99, Issue:40 Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Anticholesteremic Agents; Aphasia, Broca; Aspirin; Atorvastatin; Benzofurans; Cerebral Infarction; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Neuroprotective Agents; Plasmapheresis; Platelet Aggregation Inhibitors; Treatment Outcome	2020